Medindia

X

Providence's California Facilities Implement Allscripts Homecare

Wednesday, June 23, 2010 Corporate News J E 4
Advertisement


CHICAGO and LOS ANGELES, June 23 Providence Saint Joseph Medical Center of Burbank, Calif., and Providence Little Company of Mary Medical Center of Torrance, Calif., announced they have selected Allscripts (Nasdaq: MDRX) for their new homecare automation systems.

(Logo: http://photos.prnewswire.com/prnh/20081013/AQM041LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO)

Both California Providence hospitals will provide bidirectional interfaces between their Meditech inpatient systems and Allscripts Homecare, allowing patient demographic and insurance information to flow automatically into the homecare application.

Allscripts Homecare offers billing, scheduling, and an Electronic Health Record in a unified, seamless electronic system. When a patient is referred to a homecare agency, the staff uses the application to find out which nurse is scheduled to be in the patient's area at that time. During home visits, nurses use the EHR to document their observations and the services they have provided. The nurses can compare their assessments from previous visits while documenting current visit data. They can also generate customized care plans and OASIS quality reports for Medicare. Agency staff can track orders and create standard and customized reports, using intuitive features of the Windows-based application.

"The vision of healthcare information technology is to connect what's disconnected, including improving the critical handoffs between inpatient care and home health services," said Glen Tullman, Chief Executive Officer of Allscripts. "Providence and Allscripts share the goal of using our homecare application to improve these transitions of care and enhance home care while providing the efficiency that home health agencies need to survive and thrive."

About Providence Health & Services

Providence Health & Services extends its mission of caring and commitment across five states-- Alaska, Washington, Oregon, California, and Montana. Providence operates 27 acute care hospitals, 35 non-acute facilities, physician clinics, and a health plan. The services offered by Providence include acute and primary care, outpatient services, transitional care, home and hospice care, substance abuse programs, and mental health treatment, as well as an array of outreach programs. For more information, visit http://www2.providence.org/Pages/default.aspx.

About Allscripts

Allscripts uses innovation technology to bring health to healthcare. More than 160,000 physicians, 800 hospitals and more than 10,000 post-acute and homecare organizations utilize Allscripts to improve the health of their patients and their bottom line. The company's award-winning solutions include electronic health records, electronic prescribing, revenue cycle management, practice management, document management, care management, emergency department information systems and homecare automation. Allscripts is the brand name of Allscripts-Misys Healthcare Solutions, Inc. To learn more, visit www.allscripts.com.

For more Allscripts news, follow us on Twitter at: http://twitter.com/AllscriptsMisys

This news release may contain forward-looking statements within the meaning of the federal securities laws. Statements regarding future events, developments, the Company's future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future are forward-looking statements within the meaning of these laws. These forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, actual results may vary materially from those anticipated by the forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are: the volume and timing of systems sales and installations; length of sales cycles and the installation process; the possibility that products will not achieve or sustain market acceptance; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; competitive pressures including product offerings, pricing and promotional activities; our ability to establish and maintain strategic relationships; undetected errors or similar problems in our software products; compliance with existing laws, regulations and industry initiatives and future changes in laws or regulations in the healthcare industry; possible regulation of the Company's software by the U.S. Food and Drug Administration; the possibility of product-related liabilities; our ability to attract and retain qualified personnel; our ability to identify and complete acquisitions, manage our growth and integrate acquisitions; the ability to recognize the benefits of the merger with Misys Healthcare Systems, LLC ("MHS"); the integration of MHS with the Company and the possible disruption of current plans and operations as a result thereof; maintaining our intellectual property rights and litigation involving intellectual property rights; risks related to third-party suppliers; our ability to obtain, use or successfully integrate third-party licensed technology; breach of our security by third parties; and the risk factors detailed from time to time in our reports filed with the Securities and Exchange Commission, including our 2009 Annual Report on Form 10-K available through the Web site maintained by the Securities and Exchange Commission at www.sec.gov. The Company undertakes no obligation to update publicly any forward-looking statement, whether as a result of new information, future events or otherwise.

SOURCE Allscripts-Misys Healthcare Solutions, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Valeant Pharmaceuticals Resumes Shipment of Oxsora...
S
Molecular Detection Inc. Closes First Round of Fol...